SVB Wealth LLC Sells 11,582 Shares of Danaher Co. (NYSE:DHR)

SVB Wealth LLC trimmed its position in shares of Danaher Co. (NYSE:DHR) by 17.1% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 56,044 shares of the conglomerate’s stock after selling 11,582 shares during the quarter. SVB Wealth LLC’s holdings in Danaher were worth $12,965,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in DHR. Hamilton Point Investment Advisors LLC lifted its position in shares of Danaher by 0.9% during the fourth quarter. Hamilton Point Investment Advisors LLC now owns 42,639 shares of the conglomerate’s stock worth $9,874,000 after purchasing an additional 396 shares in the last quarter. Members Trust Co lifted its position in shares of Danaher by 1.5% during the fourth quarter. Members Trust Co now owns 6,740 shares of the conglomerate’s stock worth $1,571,000 after purchasing an additional 100 shares in the last quarter. Capital Analysts LLC lifted its position in shares of Danaher by 20.8% during the fourth quarter. Capital Analysts LLC now owns 12,801 shares of the conglomerate’s stock worth $2,961,000 after purchasing an additional 2,205 shares in the last quarter. Keel Point LLC lifted its position in shares of Danaher by 11.8% during the fourth quarter. Keel Point LLC now owns 17,285 shares of the conglomerate’s stock worth $3,999,000 after purchasing an additional 1,827 shares in the last quarter. Finally, Bourgeon Capital Management LLC lifted its position in shares of Danaher by 6.3% during the fourth quarter. Bourgeon Capital Management LLC now owns 55,683 shares of the conglomerate’s stock worth $12,882,000 after purchasing an additional 3,289 shares in the last quarter. 79.05% of the stock is owned by institutional investors.

Danaher Stock Down 0.0 %

Shares of DHR stock traded down $0.05 during trading hours on Tuesday, hitting $239.61. 701,747 shares of the company were exchanged, compared to its average volume of 2,667,551. The business has a 50 day moving average of $249.58 and a two-hundred day moving average of $229.84. The company has a current ratio of 1.68, a quick ratio of 1.37 and a debt-to-equity ratio of 0.31. Danaher Co. has a 52 week low of $182.09 and a 52 week high of $259.00. The company has a market capitalization of $177.44 billion, a PE ratio of 37.51, a PEG ratio of 3.65 and a beta of 0.83.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Tuesday, January 30th. The conglomerate reported $2.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.91 by $0.18. Danaher had a net margin of 17.26% and a return on equity of 12.25%. The company had revenue of $6.41 billion during the quarter, compared to the consensus estimate of $6.10 billion. During the same quarter in the prior year, the firm earned $2.87 earnings per share. The firm’s revenue was down 10.2% compared to the same quarter last year. Analysts anticipate that Danaher Co. will post 7.62 earnings per share for the current fiscal year.

Danaher Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 26th. Investors of record on Thursday, March 28th will be given a $0.27 dividend. The ex-dividend date of this dividend is Wednesday, March 27th. This represents a $1.08 dividend on an annualized basis and a yield of 0.45%. This is an increase from Danaher’s previous quarterly dividend of $0.24. Danaher’s dividend payout ratio (DPR) is 16.90%.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on DHR shares. Barclays increased their price objective on shares of Danaher from $240.00 to $260.00 and gave the company an “equal weight” rating in a report on Wednesday, April 10th. Raymond James increased their price objective on shares of Danaher from $240.00 to $270.00 and gave the company an “outperform” rating in a report on Wednesday, January 31st. StockNews.com lowered shares of Danaher from a “buy” rating to a “hold” rating in a report on Wednesday, January 31st. Royal Bank of Canada increased their price objective on shares of Danaher from $254.00 to $282.00 and gave the company an “outperform” rating in a report on Wednesday, January 31st. Finally, KeyCorp increased their target price on shares of Danaher from $260.00 to $290.00 and gave the stock an “overweight” rating in a report on Thursday, February 1st. Seven analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Danaher currently has an average rating of “Moderate Buy” and an average price target of $267.43.

Insider Activity at Danaher

In other news, SVP Daniel Raskas sold 23,757 shares of Danaher stock in a transaction dated Monday, February 26th. The shares were sold at an average price of $252.00, for a total value of $5,986,764.00. Following the completion of the transaction, the senior vice president now owns 38,102 shares of the company’s stock, valued at approximately $9,601,704. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other news, SVP Georgeann Couchara sold 2,622 shares of Danaher stock in a transaction dated Tuesday, February 13th. The shares were sold at an average price of $242.67, for a total value of $636,280.74. Following the completion of the transaction, the senior vice president now owns 4,244 shares of the company’s stock, valued at approximately $1,029,891.48. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP Daniel Raskas sold 23,757 shares of Danaher stock in a transaction dated Monday, February 26th. The shares were sold at an average price of $252.00, for a total transaction of $5,986,764.00. Following the completion of the transaction, the senior vice president now directly owns 38,102 shares of the company’s stock, valued at approximately $9,601,704. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 32,957 shares of company stock valued at $8,265,802. Corporate insiders own 10.90% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.